Abstract: An apparatus for generating electrical power from a flow of water, including a housing having a water inlet and water outlet, a first turbine (12) mounted in the housing for rotation about a substantially vertical axis and having a turbine shaft, a set of vertical blades (22), and a blade angle control mechanism, a second turbine (14) mounted in the housing adjacent to the first turbine, for rotation about a substantially vertical axis, the second turbine having a turbine shaft, a set of vertical blades (22) and a blade angle control mechanism, the housing being adapted to be mounted within the body of water and being so configured that an incoming water flow enters the housing via the inlet, and is principally directed into two driving flows (34, 36), one for each turbine, and is then directed for discharge via the outlet, the angle of each blade with respect to the driving water flow is controlled by the blade angle control mechanism such that a large blade surface area is presented to the incoming water fl

Abstract: One embodiment of a topper for a bed includes a liner assembly 40 having a top liner 42, a bottom liner 44 and a slip liner 70 underneath the bottom liner. The slip liner is of relatively lower friction than the top liner. An apron 62, with openings 76 therein, extends from the perimeter of the liners. Another embodiment includes a liner assembly having a top liner, a bottom liner and a slip liner underneath the bottom liner. The slip liner is of relatively lower friction than the top liner. Bridge straps 98, or 98? having a working length of at least the width of a host mattress minus the arm length of a fifth percentile female extend from the liner assembly.

Abstract: One embodiment of a topper for a bed includes a liner assembly 40 having a top liner 42, a bottom liner 44 and a slip liner 70 underneath the bottom liner. The slip liner is of relatively lower friction than the top liner. An apron 62, with openings 76 therein, extends from the perimeter of the liners. Another embodiment includes a liner assembly having a top liner, a bottom liner and a slip liner underneath the bottom liner. The slip liner is of relatively lower friction than the top liner. Bridge straps 98, or 98? having a working length of at least the width of a host mattress minus the arm length of a fifth percentile female extend from the liner assembly.

Abstract: An occupant transfer device 34 for use on a host mattress 20 having a top side 22 and a flank 24 is in the form of a fitted sheet. The device has a top 36 for covering the top side of the mattress and a skirt 38 extending from the top. The top and skirt each have an occupant side 40, 44 and a mattress side 42, 46. Substantially all of the mattress side of the top exhibits relatively low friction; the occupant side of at least the top exhibits relatively higher friction.

Abstract: An apparatus for generating electrical power from a flow of water, including a housing having a water inlet and water outlet, a first turbine (12) mounted in the housing for rotation about a substantially vertical axis and having a turbine shaft, a set of vertical blades (22), and a blade angle control mechanism, a second turbine (14) mounted in the housing adjacent to the first turbine, for rotation about a substantially vertical axis, the second turbine having a turbine shaft, a set of vertical blades (22) and a blade angle control mechanism, the housing being adapted to be mounted within the body of water and being so configured that an incoming water flow enters the housing via the inlet, and is principally directed into two driving flows (34, 36), one for each turbine, and is then directed for discharge via the outlet, the angle of each blade with respect to the driving water flow is controlled by the blade angle control mechanism such that a large blade surface area is presented to the incoming water fl

Abstract: A system for fabricating a free form structure of a composite material including carbon nanotubes. The system includes a discharge assembly and a composite formation device operatively linked with the discharge assembly. The discharge assembly dispenses a fusing agent such as for example a high energy density emission, a laser emission or a particle beam emission. The composite formation device includes a composite generator and an arranger in operative engagement with a composite generator. The composite generator engages with the fusing agent so as to create a composite nodal element. The composite nodal element includes a matrix and a multiplicity of fibers formed of carbon nanotubes dispersed throughout the matrix. The arranger positions one node relative to another to define the free form structure.

Abstract: A structure arrangement and method for the protection of a host system against an impacting ballistic element and for providing ease of mobility. The structure arrangement includes a composite. The composite includes a matrix and a multiplicity of single-walled carbon nanotubes. The single-walled carbon nanotubes are arranged with respect to the matrix so as to define an array for engagement with an impacting ballistic element.

Abstract: This invention relates to a method of treating patients afflicted with septic shock. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with heavy metal poisoning. The method includes administering to a patient in need of treatment an antidotal amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with acute renal failure. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with hangover. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with peripheral neuropathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with glycol poisoning. The method includes administering to a patient in need of treatment an antidotal amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention relates to a method of treating patients afflicted with Adult Respiratory Distress Syndrome (ARDS). The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.

Abstract: This invention describes novel formulations containing a water soluble disulfide, 2,2'-dithio-bis-ethane sulfonate, with or without cis-diammine dichloro platinum present in the same formulation, wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate is used to reduce the risk or prevent or retard the development of cisplatin induced nephrotoxicity, myelosuppression, and neurotoxicity, and wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate potentiates the antitumor activity of cisplatin when treating human patients with cancer. This invention also teaches novel formulations containing 2,2'-dithio-bis-ethane sulfonate alone or in combination with cisplatin in lyophilized or dissolved in an aqueous formulations which can be administered to patients with cancer who are being treated with cisplatin.

Abstract: This invention describes novel formulations containing a water soluble disulfide, 2,2'-dithio-bis-ethane sulfonate, with or without cis-diammine dichloro platinum present in the same formulation, wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate is used to reduce the risk or prevent or retard the development of cisplatin induced nephrotoxicity, myelosuppression, and neurotoxicity, and wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate potentiates the antitumor activity of cisplatin when treating human patients with cancer. This invention also teaches novel formulations containing 2,2'-dithio-bis-ethane sulfonate alone or in combination with cisplatin in lyophilized or dissolved in an aqueous formulations which can be administered to patients with cancer who are being treated with cisplatin.

Abstract: This invention describes novel formulations containing a water soluble disulfide, 2,2'-dithio-bis-ethane sulfonate, with or without cis-diammine dichloro platinum present in the same formulation, wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate is used to reduce the risk or prevent or retard the development of cisplatin induced nephrotoxicity, myelosuppression, and neurotoxicity, and wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate potentiates the antitumor activity of cisplatin when treating human patients with cancer. This invention also teaches novel formulations containing 2,2'-dithio-bis-ethane sulfonate alone or in combination with cisplatin in lyophilized or dissolved in an aqueous formulations which can be administered to patients with cancer who are being treated with cisplatin.

Abstract: This invention describes novel formulations containing a water soluble disulfide, 2,2'-dithio-bis-ethane sulfonate, with or without cis-diammine dichloro platinum present in the same formulation, wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate is used to reduce the risk or prevent or retard the development of cisplatin induced nephrotoxicity, myelosuppression, and neurotoxicity, and wherein the parenteral or oral administration of 2,2'-dithio-bis-ethane sulfonate potentiates the antitumor activity of cisplatin when treating human patients with cancer. This invention also teaches novel formulations containing 2,2'-dithio-bis-ethane sulfonate alone or in combination with cisplatin in lyophilized or dissolved in an aqueous formulations which can be administered to patients with cancer who are being treated with cisplatin.

Abstract: The present invention relates to compounds, compositions and methods for inhibiting gene expression. The compounds of this invention comprise 1) oligonucleoside sequences of from about 6 to about 200 bases having a three atom internucleoside linkage or 2) oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini.

Abstract: In an illustrative embodiment of the invention, a nuclear reactor pressure vessel, having an internal hoop from which the heated coolant emerges from the reactor core and passes through to the reactor outlet nozzles, is provided with sealing members operatively disposed between the outlet nozzle and the hoop. The sealing members are biased against the pressure vessel and the hoop and are connected by a leak restraining member establishing a leak-proof condition between the inlet and outlet coolants in the region about the outlet nozzle. Furthermore, the flexible responsiveness of the seal assures that the seal will not structurally couple the hoop to the pressure vessel.